(Q35748684)

10 August 2017

Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats (English)

1 reference

10 August 2017

1 reference

1

Agnieszka Nikiforuk

1 reference

10 August 2017

2

Piotr Popik

1 reference

10 August 2017

15 September 2011

1 reference

10 August 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Psychopharmacology

1 reference

10 August 2017

220

1 reference

10 August 2017

1

1 reference

10 August 2017

65-74

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-011-2487-x

10 August 2017

0 references

cites work

Translating cognition from animals to humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Neural circuits subserving behavioral flexibility and their relevance to schizophrenia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Neonatal ventral hippocampus lesions disrupt extra-dimensional shift and alter dendritic spine density in the medial prefrontal cortex of juvenile rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Neuroplasticity of neocortical circuits in schizophrenia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Seroquel restores sensorimotor gating in phencyclidine-treated rats.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Evaluation of a neurodevelopmental model of schizophrenia--early postnatal PCP treatment in attentional set-shifting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Dissociable roles for the nucleus accumbens core and shell in regulating set shifting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL/Bax ratio in the posterior cingulate cortex in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2487-X

Quetiapine ameliorates anxiety-like behavior and cognitive impairments in stressed rats: implications for the treatment of posttraumatic stress disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

The effects of intradimensional and extradimensional shifts on visual discrimination learning in humans and non-human primates

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276756

Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21918808

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-011-2487-X

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

PubMed ID

21918808